Guangzhou Kingmed Diagnostics Group Co., Ltd. Share Price
Equities
603882
CNE100002VW1
Healthcare Facilities & Services
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.74 CNY | -1.67% |
|
+0.84% | -55.67% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Enjoy this offer
* See conditions on site
| Capitalization | 12.89B 1.82B 153B | P/E ratio 2024 * |
28.5x | P/E ratio 2025 * | 14.4x |
|---|---|---|---|---|---|
| Enterprise value | 10.53B 1.49B 125B | EV / Sales 2024 * |
1.28x | EV / Sales 2025 * | 1.04x |
| Free-Float |
58.09% | Yield 2024 * |
1.83% | Yield 2025 * | 3.29% |
More valuation ratios
* Estimated data
More news
More recommendations
| 1 day | -1.67% | ||
| 1 week | +0.84% | ||
| Current month | +0.84% | ||
| 1 month | -6.63% | ||
| 3 months | -10.60% | ||
| 6 months | -50.64% | ||
| Current year | -55.67% |
1 week
25.48
28.82
1 month
25.2230.41
Current year
24.6166.87
1 year
24.6169.60
3 years
24.61124.16
5 years
24.61178.88
10 years
9.98178.88
| Director | Title | Age | Since |
|---|---|---|---|
Yao Ming Liang
CEO | Chief Executive Officer | 60 | 01/06/01 |
Bi Xi Hao
DFI | Director of Finance/CFO | 54 | 01/11/01 |
Xiao Feng Zou
BRD | Director/Board Member | 44 | 01/21/01 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yao Ming Liang
CEO | Chief Executive Officer | 60 | 01/06/01 |
Ting Yan
BRD | Director/Board Member | 55 | 01/06/01 |
Zhan Wen Zeng
BRD | Director/Board Member | 58 | 01/06/01 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.63% | 1 M€ | -20.08% | - | |
| 0.41% | 2 M€ | -14.14% | ||
| 0.37% | 12 M€ | -16.71% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -1.67% | +0.84% | -52.37% | -74.34% | 1.82B | ||
| +0.18% | -1.77% | -12.63% | -35.75% | 8.73B | ||
| -1.23% | -5.85% | +102.96% | +104.15% | 4.62B | ||
| -0.77% | -1.14% | +50.79% | -17.22% | 3.35B | ||
| -0.18% | -.--% | +21.54% | -48.56% | 2.7B | ||
| -1.05% | -2.91% | +14.49% | -68.97% | 2.06B | ||
| +4.89% | +4.89% | +16.99% | -27.26% | 1.63B | ||
| -0.26% | -0.02% | +49.65% | -25.65% | 1.31B | ||
| -2.93% | +0.75% | +90.04% | - | 1.12B | ||
| -2.50% | -7.14% | -8.77% | -56.42% | 1.08B | ||
| Average | -0.55% | -0.41% | +27.27% | -27.78% | 2.84B | |
| Weighted average by Cap. | -0.38% | -1.25% | +25.07% | -15.98% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 8.23B 1.16B 97.56B | 9.81B 1.38B 116B |
| Net income | 358M 50.47M 4.24B | 869M 123M 10.29B |
| Net Debt | -2.37B -334M -28.06B | -2.74B -386M -32.44B |
More financial data
* Estimated data
Employees
11,586
Calendar
24/10/2024
- Q3 2024 Earnings Release (Projected)
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/24/06 | 27.74 ¥ | -1.67% | 4,153,762 |
| 05/24/05 | 28.21 ¥ | +3.79% | 7,698,142 |
| 04/24/04 | 27.18 ¥ | +1.87% | 5,933,599 |
| 03/24/03 | 26.68 ¥ | +3.98% | 8,328,724 |
| 02/24/02 | 25.66 ¥ | -6.72% | 9,389,198 |
End-of-day quote Shanghai S.E., September 06, 2024
More quotes
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
27.74CNY
Average target price
32.76CNY
Spread / Average Target
+18.08%
- Stock Market
- Equities
- 603882 Stock
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition